Laboratory mice are widely used in biomedical research as models for human diseases that also provide insight into the toxicity of various xenobiotics. Fasting of mice prior to dosing is common practise in toxicological studies to ensure uniformity in drug absorption. The APAP mouse model has been extensively used for studies on pathogenesis and intervention of drug induced liver injury (DILI) based on the cytochrome P450 (CYP450) mediated formation of N-acetyl-p-benzo-quinoneimine (NAPQI). Two mouse models, out-bred CD-1 and in-bred C57BL/6J mice were used to investigate the differences in their response to acetaminophen (APAP) overdose and the effect of fasting prior to dosing to cover both acute liver injury and regeneration. The results on control mice showed that fasting alone significantly reduces the body weight up to 12%. A reduction of the glutathione (GSH) content was observed at 1 hour post dosing (hpd) in CD-1 mice and at 3 hpd in C57BL/6J mice before the levels increased gradually until the end of the study period. In fasted CD-1 mice, GSH levels returned to control levels with delay; this was variable in C57BL/6J mice until the levels were similar to control animals at 36 hpd. In both strains of fasted mice, while ATP levels remained lower, serum alanine aminotransferase (ALT) activity showed a progressive increase after APAP dosing. In fed mice, cell death via apoptosis was initially seen and most abundant at 3 and 5 hpd in CD-1 mice. In C57BL/6J mice, there was prolonged evidence of centrilobular hepatocyte necrosis, which declined but was still present at 36 hpd. In fasted mice of both strains, there was evidence of substantial ongoing hepatocyte death and neutrophil recruitment until the end of the study, together with delayed hepatocyte proliferation. Fed mice, and in particular CD-1 mice, showed higher hepatic and splenic IL-6, IL-10, NF-kB and cyclin-D1 mRNA levels than fasted mice, correlating with effective liver regeneration. The quantitative assessment of hepatocyte proliferation, based on the in situ expression of proliferating cell nuclear antigen (PCNA), confirmed the earlier onset and faster liver recovery in fed animals, with an earlier onset also in CD-1 than C57BL/6J mice. In conclusion, we provide definite evidence that fasting prior to APAP overdose does not only modulate the resulting liver injury, but delay the subsequent liver regeneration. We also confirm that the C57BL/6J mice are more susceptible to APAP-induced liver injury when fed prior to dosing, but both strains react in a similar way when dosed after a period of fasting.
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Laboratory mice are widely used in biomedical research as models for human diseases that also provide insight into the toxicity of various xenobiotics. Fasting of mice prior to dosing is common practise in toxicological studies to ensure uniformity in drug absorption. The APAP mouse model has been extensively used for studies on pathogenesis and intervention of drug induced liver injury (DILI) based on the cytochrome P450 (CYP450) mediated formation of N-acetyl-p-benzo-quinoneimine (NAPQI). Two mouse models, out-bred CD-1 and in-bred C57BL/6J mice were used to investigate the differences in their response to acetaminophen (APAP) overdose and the effect of fasting prior to dosing to cover both acute liver injury and regeneration. The results on control mice showed that fasting alone significantly reduces the body weight up to 12%. A reduction of the glutathione (GSH) content was observed at 1 hour post dosing (hpd) in CD-1 mice and at 3 hpd in C57BL/6J mice before the levels increased gradually until the end of the study period. In fasted CD-1 mice, GSH levels returned to control levels with delay; this was variable in C57BL/6J mice until the levels were similar to control animals at 36 hpd. In both strains of fasted mice, while ATP levels remained lower, serum alanine aminotransferase (ALT) activity showed a progressive increase after APAP dosing. In fed mice, cell death via apoptosis was initially seen and most abundant at 3 and 5 hpd in CD-1 mice. In C57BL/6J mice, there was prolonged evidence of centrilobular hepatocyte necrosis, which declined but was still present at 36 hpd. In fasted mice of both strains, there was evidence of substantial ongoing hepatocyte death and neutrophil recruitment until the end of the study, together with delayed hepatocyte proliferation. Fed mice, and in particular CD-1 mice, showed higher hepatic and splenic IL-6, IL-10, NF-kB and cyclin-D1 mRNA levels than fasted mice, correlating with effective liver regeneration. The quantitative assessment of hepatocyte proliferation, based on the in situ expression of proliferating cell nuclear antigen (PCNA), confirmed the earlier onset and faster liver recovery in fed animals, with an earlier onset also in CD-1 than C57BL/6J mice. In conclusion, we provide definite evidence that fasting prior to APAP overdose does not only modulate the resulting liver injury, but delay the subsequent liver regeneration. We also confirm that the C57BL/6J mice are more susceptible to APAP-induced liver injury when fed prior to dosing, but both strains react in a similar way when dosed after a period of fasting. In Set 1, baseline total cell count obtained from bronchoalveolar fluid (BALF) was 105,000 ± 70,000 cells and increased to 3,072,917 ± 510,417 after LPS (p<0.001). Pretreatment with 500 mg/kg (effective dose) of either bignay or mulberry substantially inhibited the cellular infiltrates surrounding the airways caused by LPS (p<0.05 vs LPS). Secreted IL-6 obtained from BALF after LPS was 1,353.6 pg/ml vs 39.32 ± 15.9 pg/ml for PBS mice (p<0.01). Extracted bignay extract but not mulberry was effective in inhibiting the endogenously secreted IL-6. We also determined the total lung protein content in treated mice. Intratracheal administration of LPS caused 1,021 ±384 µg/ml vs 87.25 ± 23 for PBS mice (p<0.002). A 2-fold decrease in protein content was observed for mice receiving bignay (582.9 ± 181; p<0.05 vs LPS) and 733 ± 190 for mulberry treated mice (p=NS vs LPS). Morphological analysis of excised lung stained with H&E demonstrated that LPS caused inflammatory cellular infiltrates surrounding the airways, and was inhibited substantially by 500 mg/kg bignay and 500 mg/kg mulberry extracts given intraperitoneally at different time points (1, 2, 3, and 4 hrs; 2 hrs as effective time). To assess the acute toxicity test for bignay, OECD 423 was used (n=20 male, 20 female mice). Increasing dose of bignay, 500 mg/kg, 1000 mg/kg and 2000 mg/ kg, was administered via gavage (n=5 male, 5 female/dose). We observed that bignay did not exhibit physiologic, behavioral, and neurologic lethal reactions to mice at any dose tested. Hematology and blood chemistry values were not altered. Gross and histological examination of different vital organs revealed no significant morphometric changes compared to control mice (n=5 male, 5 female mice).
In Set 2 experiments, Evans blue dye, an index of murine model of acute lung injury, was injected via tail vein 2 hrs post LPS treatment. LPS alone caused significant increase in lung leakage as indicated by blue coloration of the lung compared to control PBS injected mice. At 500 mg/kg, bignay and mulberry prevented comparably the vascular leakage caused by LPS; 10 mg/kg i.p. Fluticasone serves as positive control. We demonstrate for the first time that both fruits are effective in preventing acute pulmonary inflammation and acute lung injury caused by LPS in Balb/c mice. These data further suggest that LPS causes the release of IL-6, which enhances lung inflammation, was attenuated significantly by bignay and to a lesser extent with mulberry. As the porcine heart morphologically and physiologically closely resembles to that of humans, utilising porcine models in cardiovascular studies therefore, is imperative in reducing mortality and morbidity of cardiovascular disease in the years to come.
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Psychotria sarmentosa (named "Gonica" in Sinhala, Family; Rubiaceae) has a long history of use in the folk medicine in Sri Lanka and it has wide popularity in the community as a leafy vegetable. Indigenous healers prescribe an aqueous extract of leaves for individuals who have been physically assaulted, indicating that it may possess potent analgesic and/or anti-inflammatory activity. The literature survey revealed that published scientific information on the medicinal value of this plant is scarce. Hence, present studies have been aimed to evaluate the anti-inflammatory activity and possible mechanisms which could be contributing for the anti-inflammatory action of aqueous extract of fresh leaves of Psychotria sarmentosa (AELP). Healthy adult, male Wistar rats weighing 150 -200 g were used for each experiments (n=6/group). Rats were housed under standard conditions with a natural light dark cycle and fed with standard diet and clean fresh water ad libitum. The animals were acclimatized for at least one week to the laboratory conditions before commencing each experiments and 3 R principal was applied at all times. Ethical clearance (No. 30/14, 35/15) was obtained from Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka. The acute and sub chronic anti-inflammatory activities of leaves of P. sarmentosa were evaluated by using carrageenan and formaldehyde induced rat hind paw oedema method respectively. Chronic antiinflammatory activity was assessed with adjuvant induced arthritis (AIA) rat model. The anti-histamine and anti-nociceptive activities were evaluated by using histamine induced wheal formation test and acetic acid induced writhing test respectively. In an attempt to evaluate the in vivo lipid peroxidation activity, thiobarbituric acid reactive substance (TBARS) assay was used and in vitro anti-oxidant activity was assessed with DPPH radical scavenging assay. The results of each experiment were compared with negative and positive controls and p < 0.05, was considered as statistically significant. Acute and sub chronic toxicity studies were conducted to evaluate the safety. The results showed that the treatment with different doses of AELP, significantly (p < 0.05) reduced the paw oedema formation when compared with negative control. The dose of 100 mg/kg of AELP exhibited the maximum percentage inhibition (66.0%) of paw oedema formation was used as the effective dose in subsequent experiments. In AIA rat model also, AELP showed a marked reduction of oedema formation in injected paw. Further, it showed a marked reduction of loss of body weight and prostaglandin E 2 level. These findings scientifically prove that AELP has a potent acute, sub chronic and chronic anti-inflammatory activity in Wistar rats. Further, AELP showed significant anti-histamine, anti-nociceptive and in-vivo and iv-vitro anti-oxidant activity which may be contributed for its' antiinflammatory activity. In the toxicity study, the test animals at all doses levels showed no significant changes in all parameters including histology.
In conclusion, these observations provide evidence for the anti-inflammatory properties and its' possible mechanisms of these actions. Activity guided fractionation has yielded several active fractions from which partial identification of compounds have been done. Further studies will be undertaken to complete structural elucidation and bioactivity of isolated compounds. 
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Intestinal calcium absorption is markedly enhanced during pregnancy and lactation, which is essential for fetal growth and milk production, respectively. On the other hand, inadequate calcium intake could induce bone loss and osteoporosis in lactating mother. Thus, the understanding of how to improve intestinal calcium absorption has to be investigated to alleviate the lactation-induced bone loss. Since prolactin （PRL), a pituitary hormone, has been known to enhance intestinal calcium absorption during reproductive periods, our study aimed to demonstrate the genomic effect of PRL in hyperprolactinemic rats, including pregnant, lactating, and pituitary-grafted hyperprolactinemic rats. Female Sprague-Dawley rats （8-week-old, weighing 180-200 g) were subjected to pituitary transplantation to increase plasma PRL levels [anterior pituitary （AP)-grafted rat model]. At week 4, the expression of genes related to calcium transport in the duodenal epithelial cells was determined. In another series of experiments, day-14 pregnant and day-1 lactating rats were injected for 7 days with bromocriptine to inhibit pituitary PRL secretion. Age-matched pregnant or lactating rats or nulliparous rats injected with normal saline were used as control groups. The mRNA levels were determined by quantitative real-time PCR. Highthroughput microarray technique was developed and custom-designed to reveal the expression of genes related to nutrient and ion absorption in the duodenal enterocytes. This study has been approved by the animal ethics committee of Faculty of Science, Mahidol University, Thailand. The results showed that the expressions of calcium transportrelated genes, i.e., TRPV5, TRPV6, calbindin-D 9k , and claudin-3 were upregulated in the 4-week APgrafted rats. The upregulation of TRPV6 and ZO-1 expression was observed in pregnant rats, while upregulation of TRPV6, PMCA1b, ZO-1 and claudin-12 was found in lactating rats. Some overexpressed genes, e.g., TRPV6, PMCA1b, and ZO-1, were downregulated after bromocriptine administration. Microarray further detected changes in the expression of several genes related to calcium, nutrient, and ion transport, such as TRRM7 and NaPi-IIb, consistent with findings from the realtime PCR study. These PRL actions predominantly occurred in the intestinal villous cells, but not the crypt cells. In conclusion, PRL was found to increase the intestinal calcium absorption by upregulating the expression of genes related to calcium transport. The present findings not only explain the stimulatory effects of PRL on nutrient absorption and provision of precursors for milk production but also suggest an approach for oral calcium supplementation based on physiological action of PRL.
